BDNF/TrkB signaling as an anti-tumor target

Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer

(2011) Neill Patani et al.   Cancer Cell International

Brain-Derived Neurotrophic Factor Promotes Tumorigenesis via Induction of Neovascularization: Implication in Hepatocellular Carcinoma

(2011) C.-T. Lam et al.   CLINICAL CANCER RESEARCH

Role and Relevance of TrkB Mutations and Expression in Non-Small Cell Lung Cancer

(2011) T. Harada et al.   CLINICAL CANCER RESEARCH

Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival

(2011) E. Vanhecke et al.   CLINICAL CANCER RESEARCH

BDNF/TrkB Content and Interaction with Gastrin-Releasing Peptide Receptor Blockade in Colorectal Cancer

(2011) Caroline Brunetto de Farias et al.   ONCOLOGY

Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix

(2011) Ahrim Moon et al.   PATHOLOGY

Functional Characterization of Human Cancer-Derived TRKB Mutations

(2011) Thomas R. Geiger et al.   PLoS One

Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer

(2010) Huang   INTERNATIONAL JOURNAL OF ONCOLOGY

On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology

(2009) C. J. Thiele et al.   CLINICAL CANCER RESEARCH

BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells

(2009) Anna Laura Schmidt et al.   JOURNAL OF MOLECULAR NEUROSCIENCE